Want to see KR:234080 full AI Analyst Report?
JW LIFESCIENCE CORPORATION (234080) Income Statement
JW LIFESCIENCE CORPORATION Income Statement
Last quarter (Q2 2026), JW LIFESCIENCE CORPORATION's total revenue was $63.25B, an increase of 15.61% from the same quarter last year. In Q2, JW LIFESCIENCE CORPORATION's net income was $8.01B. See JW LIFESCIENCE CORPORATION’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 257.83B | $ 222.48B | $ 206.86B | $ 188.93B | $ 169.82B | |
| $ 69.77B | $ 57.51B | $ 52.35B | $ 48.12B | $ 49.16B | |
| $ 36.53B | $ 21.65B | $ 21.53B | $ 21.03B | $ 20.74B | |
| Depreciation and Amortization | $ 18.17B | $ 15.74B | $ 15.53B | $ 14.96B | $ 13.24B |
| $ 51.41B | $ 76.82B | $ 50.83B | $ 43.75B | $ 37.59B | |
| $ 33.30B | $ 35.86B | $ 30.86B | $ 27.09B | $ 28.42B | |
| $ -1.50B | $ 23.17B | $ 2.85B | $ -6.31B | $ -10.13B | |
| $ 31.75B | $ 59.03B | $ 33.71B | $ 20.78B | $ 18.29B | |
| $ 28.61B | $ 43.99B | $ 28.14B | $ 14.96B | $ 12.91B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1847.38 | $ 2842.77 | $ 1817.55 | $ 966.21 | $ 828.84 |
| Diluted EPS | $ 1847.38 | $ 2842.77 | $ 1817.55 | $ 966.21 | $ 828.84 |
| Weighted Average Shares Outstanding | 15.45M | 15.48M | 15.48M | 15.48M | 15.58M |
| Weighted Average Shares Outstanding (Diluted) | 15.45M | 15.48M | 15.48M | 15.48M | 15.58M |
Currency in KRW